Welcome to our dedicated page for THRIVE SERIES TRUST news (Ticker: THRV), a resource for investors and traders seeking the latest updates and insights on THRIVE SERIES TRUST stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect THRIVE SERIES TRUST's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of THRIVE SERIES TRUST's position in the market.
Prospera Funds Inc. has launched its inaugural ETF, the Prospera Income ETF (NASDAQ: THRV), designed to deliver monthly distributions 3-4% above the 10-year U.S. Treasury yield. The actively managed fund combines high-quality fixed income ETFs with tactical allocations to CEFs, dividend stocks, preferred shares, REITs, and commodities.
Led by industry veteran Peter Montalbano, with over 24 years of experience, the ETF features an 'Always On' protection strategy, maintaining 0.25% in protective puts that can be increased to 10% during volatile periods. The investment team, with 60+ years of combined experience, includes co-portfolio managers Michael Lowenberg and Kris Wild.
FAQ
What is the current stock price of THRIVE SERIES TRUST (THRV)?
